ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO1146

Defining the Cytoskeletal Interactome of the Proximal Tubule: A Network Analysis of Payload-Specific Antibody-Drug Conjugate Nephrotoxicity

Session Information

Category: Onconephrology

  • 1600 Onconephrology

Authors

  • Capriles, Guido M., TriHealth Inc, Cincinnati, Ohio, United States
  • Abdeltawwab, Mohannad, TriHealth Inc, Cincinnati, Ohio, United States
  • Rajput, Amit K., TriHealth Inc, Cincinnati, Ohio, United States
Background

The clinical integration of Monomethyl Auristatin E (MMAE)-based antibody-drug conjugates (ADCs) has revealed unexpected acute kidney injury (AKI) (Atemnkeng et al., 2023). Unlike Topoisomerase-I (Topo-I) ADCs, MMAE payloads function as microtubule depolymerizing agents. Because the proximal tubule (PT) relies heavily on dynamic cytoskeletal networks to maintain a polarized reabsorptive phenotype, we hypothesized MMAE-induced microtubule inhibition disproportionately dismantles the functional PT interactome compared to nuclear-targeted therapies.

Methods

To explore structural dependencies of PT physiology on distinct ADC targets, an in-silico protein-protein interaction (PPI) network analysis was conducted (STRING v12.5). Structural interactomes of MMAE targets (TUBB/TUBA1A) and Topo-I targets (TOP1) were modeled against core PT functional mediators: apical endocytosis (LRP2), vesicular recycling (RAB11A), and solute transport (SLC9A3, ATP1A1). Networks were filtered for high-confidence human interactions (>0.700). Functional integration was quantified via False Discovery Rate (FDR).

Results

Network modeling revealed a payload-specific structural vulnerability. The MMAE target network demonstrated highly significant functional integration with core PT mediators, forming a tightly bound structural interactome (26 nodes, 50 edges; PPI enrichment p=3.19e-08). Disruption of this cytoskeletal node mathematically destabilized networks essential for 'apical part of cell' maintenance (FDR=5.99e-06), 'brush border membrane' scaffolding (FDR=0.0014), and 'endocytic vesicle' localization (FDR=0.0016). Conversely, the TOP1 interactome remained structurally segregated, exhibiting zero high-confidence interactions bridging the nuclear target to PT transport or polarity networks.

Conclusion

This computational interactome analysis provides a physiological framework for MMAE-associated AKI. The proximal tubule’s absolute reliance on intact microtubule networks for polarized vesicular transport represents a profound structural vulnerability to tubulin-inhibiting ADCs. These in-silico findings propose targeted disruption of the PT cytoskeletal interactome as a primary mechanism for payload-specific tubular toxicity, establishing a foundation for in-vitro validation.